"The third quarter of 2024 was transformative for BioAge as we achieved two major milestones: initiating our Phase 2 STRIDES trial evaluating azelaprag in combination with tirzepatide, and completing ...

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...

Investors can apply for a minimum of 200 shares and its multiples thereafter. The IPO of Zinka Logistics includes a fresh shares sale of Rs 550 crore, while shareholders and promoters will offload ...

But, what is emboldening the startups to revisit their IPO plans, a year after many of them shelved or postponed their plans? The answer is the thawing funding winter, a renewed push for ...

BioAge Labs (BIOA) announced that it will present new preclinical data for its lead product candidate azelaprag, an orally available small ...

SINGAPORE: The retail offering for the initial public offering (IPO) of Malaysia’s top mini-market chain 99 Speed Mart Retail Holdings has been oversubscribed by 3.04 times, the issue’s ...

PETALING JAYA: ACE Market-bound Northeast Group Bhd’s issue of 37 million shares to the public has been oversubscribed by 73.42 times, according to the Malaysian Issuing House Sdn Bhd.

This page features the latest news about the Bioage Labs stock. BioAge Labs director Enright buys $7.2 million in stock BioAge Labs, Inc. (NASDAQ:BIOA) has seen significant insider activity as ...

Niva Bupa Health Insurance IPO offers a fresh issue and an offer-for-sale (OFS) component, which opened for subscription on November 7. The public offer was subscribed 65 per cent on Day 1.

According to a prospectus on the IPO, Zenas ended the second quarter with around $184 million in cash and has earmarked most of the IPO proceeds for obexelimab's clinical trials programme ...

Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.